America's IVD Reckoning: Pure Global on the End of LDTs episode artwork

EPISODE · Feb 27, 2026 · 1 MIN

America's IVD Reckoning: Pure Global on the End of LDTs

from MedTech Global Insights

The FDA is finalizing a historic rule change, bringing thousands of Laboratory Developed Tests (LDTs) under the full umbrella of medical device regulation. This move ends decades of a special 'enforcement discretion' policy and will fundamentally reshape the diagnostics industry in the United States, impacting everyone from university hospitals to commercial labs. We unpack what this means for the entire MedTech ecosystem. The shift from a lab-centric framework to the FDA's rigorous quality system and premarket approval process presents immense operational, financial, and strategic challenges. We explore the new reality for labs who are now, in the eyes of the regulator, medical device manufacturers. A real-world case: Imagine a leading cancer center that developed a groundbreaking liquid biopsy test for early pancreatic cancer detection. Under the old system, they could offer it to their patients quickly. Under the new rule, they are now considered a device manufacturer. They face the daunting, multi-million dollar task of submitting for FDA premarket approval, a process for which their research-focused staff has no experience. This could delay patient access to a life-saving test by years. 本期干货: 1. What is the FDA's LDT final rule and why is it happening now? 2. How does this rule reclassify a clinical laboratory as a manufacturer? 3. What are the key differences between the old CLIA rules and the new FDA Quality System requirements? 4. What does the premarket approval pathway now look like for a test that was formerly an LDT? 5. Could this new rule unintentionally stifle diagnostic innovation for rare diseases? 6. What are the new post-market surveillance responsibilities labs must now adopt? 7. How can labs begin preparing their technical dossiers for FDA submission today? 8. What opportunities does this regulatory shift create for established IVD companies? Contact us at [email protected] or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.

Episode metadata supplied by the publisher feed · Published Feb 27, 2026

Embed this episode

NOW PLAYING

America's IVD Reckoning: Pure Global on the End of LDTs

0:00 1:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedTech Global Insights?

This episode is 1 minute long.

When was this MedTech Global Insights episode published?

This episode was published on February 27, 2026.

Can I download this MedTech Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!